Ketosaid 99.96% W/W Oral Solution
Revised: 28th August 2008
AN: 02089/2007
SUMMARY OF PRODUCT CHARACTERISTICS
1. Name of the veterinary medicinal product
Ketosaid 99.96% w/w Oral Solution
2. Qualitative and quantitative composition
Active Substance:
Each ml contains 0.9996 ml of active substance
Qualitative composition Quantitative composition
Propylene glycol 99.96% w/w
Excipients:
Carmoisine 0.04% w/w
For a full list of excipients, see section 6.1
3. Pharmaceutical form
Oral solution
A red, viscous, non-aqueous solution
4. Clinical Particulars
4.1 Target species
Cattle
Sheep
4.2 Indications for use, specifying the target species
Ketosaid is used as an aid in the treatment of acetonaemia and ketosis in cattle and sheep.
4.3 Contraindications
For oral administration only.
4.4 Special Warnings for each target species
None
4.5 Special precautions for use
Special precautions for use in animals
As Ketosis in sheep arises from prenatal metabolic stress, treatment with Ketosaid may be continued until symptoms resolve or until parturition. During this time a general improvement in nutritional status is recommended.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
In case of accidental eye contact, wash eyes with plenty of clean water. If irritation occurs, seek medical attention. In case of contact with skin, remove any contaminated clothing and wash affected area thoroughly with soap and water. If irritation occurs seek medical advice.
Ingestion: If accidentally swallowed, seek medical advice.
Wash hands after use.
4.6 Adverse reactions (frequency and seriousness)
No known undesirable effects.
4.7 Use during pregnancy, lactation or lay
Ketosaid can be safely administered to pregnant and lactating animals.
4.8 Interaction with other medicinal products and other forms of interaction
None
4.9 Amounts to be administered and administration route
Cattle: 200 ml twice daily on first day and 100 ml twice daily for next three days, administered orally as a drench.
Sheep: 100 ml daily for four days, administered orally as a drench.
Prior to administration, doses should be measured accurately by decanting Ketosaid from this container into a clear, dry, suitably sized vessel graduated in millilitres (e.g. measuring jug).
Overdose (symptoms, emergency procedures, antidotes), if necessary
None
Withdrawal period
Meat: Zero days
Milk: Zero hours
5. pharmacological properties
Pharmacotherapeutic group: Propylene Glycol
ATC Vet Code: QA16QA01
5.1 Pharmacodynamic properties
Propylene glycol is present as an energy source. It is readily absorbed from the rumen and is glycogenic, the intermediate oxidation products being pyruvate and lactate. When administered over a 3- 4 day period propylene glycol is effective in elevating blood glucose levels.
6. Pharmaceutical particulars
6.1 List of excipients
Carmoisine (E122)
6.2 Incompatibilities
None known
Shelf life
Shelf life of the veterinary medicinal product as packaged for sale: 2 years
Special precautions for storage
Do not store above 25oC.
Nature and composition of immediate packaging
A white, opaque, high density polyethylene can, with a white polypropylene cap (screw fit). Contains either; 1, 2.5, 5 and 10 litres.
Not all pack sizes may be marketed.
Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
7. MARKETING AUTHORISATION HOLDER
Norbrook Laboratories Limited
Station Works
Newry
Co. Down, BT35 6JP
Northern Ireland
8. MARKETING AUTHORISATION NUMBER(S)
Vm 02000/4072
DATE OF FIRST AUTHORISATION
30 June 1986
10. DATE OF REVISION OF THE TEXT
28 August 2008